Are you Dr. Bierman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 58 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
988102 Nebraska Medical Ctr
Omaha, NE 68198Phone+1 402-559-9800Fax+1 402-559-4835- Is this information wrong?
Summary
- Dr. Philip Bierman, MD is an oncologist in Omaha, Nebraska. He is currently licensed to practice medicine in Nebraska, California, and Iowa. He is affiliated with Nebraska Medicine - Nebraska Medical Center, Nebraska Medicine - Bellevue, and Veterans Affairs Nebraska-Western Iowa Health Care System - Lincoln.
Education & Training
- City of Hope National Medical CenterFellowship, Hematology and Medical Oncology, 1985 - 1986
- University of Nebraska Medical Center College of MedicineFellowship, Hematology and Medical Oncology, 1983 - 1985
- University of Nebraska Medical Center College of MedicineResidency, Internal Medicine, 1979 - 1983
- University of Missouri Kansas City School of MedicineClass of 1979
Certifications & Licensure
- CA State Medical License 1985 - Present
- NE State Medical License 1981 - 2024
- IA State Medical License 1982 - 2005
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
Clinical Trials
- Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy Start of enrollment: 2008 Jun 01
- Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2009 Apr 15
- Leukine (Sargramostim) for Parkinson's Disease Start of enrollment: 2013 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsLenalidomide maintenance following high-dose therapy and autologous haematopoietic stem cell transplantation in chemo-resistant or high-risk non-Hodgkin lymphoma: A ph...Julie M Vose, Siddhartha Ganguly, Philip J Bierman, R Gregory Bociek, Matthew Lunning, Liz Lyden, Jane L Meza, Paolo F Caimi, James O Armitage> ;British Journal of Haematology. 2023 Jul 1
- 1 citationsPhase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma.Mridula Krishnan, R. Gregory Bociek, Michelle A. Fanale, Swaminathan P. Iyer, Mary Jo Lechowicz, Philip J. Bierman, James O. Armitage, Matthew A. Lunning, Avyakta Kall...> ;Annals of Hematology. 2021 Oct 20
- 58 citationsPretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement.David P. Al-Adra, Laura L. Hammel, John P. Roberts, E. Steve Woodle, Deborah Levine, Didier A. Mandelbrot, Elizabeth C. Verna, Jayme E. Locke, Jonathan D'Cunha, Maryja...> ;American Journal of Transplantation. 2021 Feb 1
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- Nebraska Medicine - BellevueBellevue, Nebraska
- Veterans Affairs Nebraska-Western Iowa Health Care System - LincolnLincoln, Nebraska
- Nebraska Medicine - Nebraska Medical CenterOmaha, Nebraska
- Bryan Medical CenterLincoln, Nebraska
- Bryan Medical CenterLincoln, Nebraska
- Bryan Medical CenterLincoln, Nebraska
- Bryan Medical CenterLincoln, Nebraska
- Bryan Medical CenterLincoln, Nebraska
- Bryan Medical CenterLincoln, Nebraska